Jami K. Nachtsheim - 06 Jul 2023 Form 4 Insider Report for Telesis Bio Inc. (TBIO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 May 2024, 19:11:41 UTC
Prior SEC filing
09 Jun 2023
Next SEC filing
26 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jami Nachtsheim

Key filing fact

Jami K. Nachtsheim filed Form 4 for Telesis Bio Inc. (TBIO) on 03 May 2024.

Key facts

  • This page summarizes Jami K. Nachtsheim's Form 4 filing for Telesis Bio Inc. (TBIO).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 03 May 2024, 19:11.

Change

  • Previous filing in this sequence was filed on 09 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TBIO transaction

Common Stock

Award

Transaction value
$0
Shares
+46,752
Change %
+227%
Price
$0.000000
Shares after
67,382
Date
06 Jul 2023
Ownership
Direct
Footnotes
F1
TBIO transaction

Common Stock

Award

Transaction value
$0
Shares
+34,297
Change %
+51%
Price
$0.000000
Shares after
101,679
Date
01 May 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TBIO transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+70,129
Change %
Price
$0.000000
Shares after
70,129
Date
06 Jul 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
70,129
Exercise price
$1.54
Footnotes
F3
TBIO transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+30,362
Change %
Price
$0.000000
Shares after
30,362
Date
01 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,362
Exercise price
$0.3557
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.

Footnote F2

The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 14,056 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.

Footnote F3

Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .